# Genmab Adopts ChatGPT Enterprise in "AI Everywhere" Initiative

OpenAI announced that Genmab, a biotechnology company, has launched an "AI Everywhere" initiative powered by ChatGPT Enterprise. The deployment comes with OpenAI's assurances around security and privacy protections.

The move signals growing enterprise adoption of AI tools in the pharmaceutical and biotech sectors. ChatGPT Enterprise offers companies dedicated capacity, enhanced security features, and data privacy guarantees that prevent OpenAI from training on customer data—critical considerations for regulated industries handling sensitive research and patient information.

For Genmab, integrating AI across their operations could accelerate drug discovery processes, streamline research documentation, and improve internal knowledge management. The "AI Everywhere" branding suggests a comprehensive rollout rather than limited pilot testing.

This announcement, shared by OpenAI's official account, highlights how AI platforms are moving